Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Is IVL safe for patients with diabetes?
New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.
FDA announces Class I recall of patches used for heart surgery
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.
Catheters recalled due to defect—FDA highlights risk of stroke or brain damage
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.
IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.
FDA clears new-look robotic system from Stereotaxis
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

Study the signs: The most common symptoms of 6 cardiovascular diseases

A new scientific statement details the most common symptoms associated with heart attacks, heart failure and other cardiac conditions. Importantly, the authors wrote, clinicians must remember that symptoms can vary between men and women.

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

The historic procedure took approximately 30 minutes, and the patient went home that same day.

Boston Scientific acquires startup behind new FDA-cleared embolization technology

The new hydrogel material was designed to immediately conform to the patient's body and create a barrier.

The Harmony pulmonary valve was among the devices involved with the FDA Breakthrough Device Designation program that gained more rapid market clearance. The FDA graph shows cardiovascular devices leading the types of devices involved in the program.

Cardiovascular devices lead FDA Breakthrough Device Designation program

The FDA said cardiovascular devices make up the largest number of technologies accepted into the Breakthrough Devices Program, and several are on the list of the first 50 in the program to gain market clearance.

Cardiologists sound the alarm as ‘staggering’ new data suggest CVD rates in the U.S. will rise dramatically

New data from the CDC and U.S. Census Bureau show just how bad CVD rates could get in the next few decades. Specialists agree that a lot of work is needed to help keep these estimates from becoming a reality.

Peripheral artery disease patients benefit if they push through discomfort when walking

Researchers said they were surprised to learn that "no pain, no gain" was so accurate for this patient population.

Programmable RNA-DNA anticoagulant fibers may provide a better balance between blood clots and bleeding risks

“We can learn from nature, but we have built something that has never been introduced before,” one researcher said.

Catheter-directed thrombolysis boosts survival rates for submassive pulmonary embolism

The new meta-analysis included data from nearly 10,000 patients.

Vascular & Endovascular

Is IVL safe for patients with diabetes?

FDA announces Class I recall of patches used for heart surgery

Catheters recalled due to defect—FDA highlights risk of stroke or brain damage

IVC filter recalled due to injury risk

FDA clears new-look robotic system from Stereotaxis